KR101407231B1 - Method for producing fermented herb extract with high GABA content using Lactobacillus helveticus RMK85 - Google Patents

Method for producing fermented herb extract with high GABA content using Lactobacillus helveticus RMK85 Download PDF

Info

Publication number
KR101407231B1
KR101407231B1 KR1020120086900A KR20120086900A KR101407231B1 KR 101407231 B1 KR101407231 B1 KR 101407231B1 KR 1020120086900 A KR1020120086900 A KR 1020120086900A KR 20120086900 A KR20120086900 A KR 20120086900A KR 101407231 B1 KR101407231 B1 KR 101407231B1
Authority
KR
South Korea
Prior art keywords
gaba
extract
lactobacillus helveticus
starter
rmk85
Prior art date
Application number
KR1020120086900A
Other languages
Korean (ko)
Other versions
KR20140020470A (en
Inventor
이삼빈
양선아
김지은
김민아
임상동
허담
최성기
이준엽
박수현
Original Assignee
계명대학교 산학협력단
주식회사 비락
(주)옴니허브
한국식품연구원
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 계명대학교 산학협력단, 주식회사 비락, (주)옴니허브, 한국식품연구원 filed Critical 계명대학교 산학협력단
Priority to KR1020120086900A priority Critical patent/KR101407231B1/en
Publication of KR20140020470A publication Critical patent/KR20140020470A/en
Application granted granted Critical
Publication of KR101407231B1 publication Critical patent/KR101407231B1/en

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/69Polygalaceae (Milkwort family)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/888Araceae (Arum family), e.g. caladium, calla lily or skunk cabbage

Abstract

본 발명은 락토바실러스 헬베티커스 RMK85를 이용한 GABA 증진 발효 식물 추출물 제조방법에 관한 것으로서, 배지에서 락토바실러스 헬베티커스를 배양하여 스타터(starter)를 준비하는 단계; 상기 락토바실러스 헬베티커스 스타터를 0.1 내지 10 중량% 글루코즈(glucose) 및 0.1 내지 5 중량% 효모추출물(yeast extract)이 포함된 생약 추출물에 접종하는 단계; 및 상기 접종된 생약 추출물을 발효시키는 단계를 포함하는 감마-아미노뷰티르산(gamma-aminobutyric acid; GABA)이 증진된 발효 생약 추출물 제조방법을 제공한다. 상세하게는, 상기 배지에는 0.1 내지 1 중량% 모노소듐 글루타메이트(mono sodium glutamate; MSG)를 더 첨가하는 것을 특징으로 한다. 또한 상기의 방법에 의해 제조된 GABA가 증진된 발효 생약 추출물을 제공한다.The present invention relates to a method for producing a GABA-enhanced fermentation plant extract using Lactobacillus helveticus RMK85, comprising the steps of: preparing a starter by culturing Lactobacillus helveticus in a medium; Inoculating the Lactobacillus helveticus starter with a crude drug extract containing 0.1 to 10% by weight glucose and 0.1 to 5% by weight yeast extract; And a step of fermenting the inoculated herbal medicine extract, wherein the gamma-aminobutyric acid (GABA) is promoted. Specifically, the medium is further supplemented with 0.1 to 1% by weight of monosodium glutamate (MSG). Also provided is a fermented herbal medicine extract having enhanced GABA produced by the above method.

Description

락토바실러스 헬베티커스 RMK85를 이용한 GABA 증진 발효 식물 추출물 제조방법{Method for producing fermented herb extract with high GABA content using Lactobacillus helveticus RMK85}FIELD OF THE INVENTION [0001] The present invention relates to a method for producing a GABA-enhanced fermented plant extract using Lactobacillus helveticus RMK85,

본 발명은 락토바실러스 헬베티커스(Lactobacillus helveticus) RMK85를 이용하여 감마-아미노뷰티르산(gamma-aminobutyric acid; GABA)이 증진된 발효 생약 추출물 제조방법에 관한 것이다.The present invention relates to Lactobacillus < RTI ID = 0.0 > The present invention relates to a method for producing a fermented herbal medicine extract in which gamma-aminobutyric acid (GABA) is promoted using helveticus RMK85.

감마-아미노뷰티르산(gamma-aminobutyric acid; GABA)은 억제성 신경전달물질로서 혈압상승을 억제하고 시력증진에 효과가 있으며 불안감, 초조감 등을 진정시키는 작용을 하는 것으로 알려진 물질이다. 동물의 경우 뇌, 심장, 폐, 신장 등에 분포되어 있으며, 식물의 경우 발아현미, 녹차 등에서 주로 발견되고 있다. 스트레스에 시달리는 현대인이나 수험생, 알코올 과다 섭취자의 경우 뇌와 혈중 GABA 농도가 낮은 것으로 보고되어 있으며, 체내 GABA 농도의 극심한 부족은 발작, 경련, 간질 증세를 일으키는 것으로 알려져 있다.Gamma-aminobutyric acid (GABA) is an inhibitory neurotransmitter, which is known to inhibit blood pressure buildup, improve visual acuity, and calm anxiety and nervousness. In animals, it is distributed in the brain, heart, lung, kidney, etc. In the case of plants, it is mainly found in germinated brown rice and green tea. Hypnotists, examinees, and alcohol-consuming sufferers suffering from stress are reported to have low levels of GABA in the brain and blood, and a severe shortage of GABA in the body is known to cause seizures, convulsions, and epilepsy.

이러한 GABA의 기능성이 알려지면서 의약품으로서 뿐만 아니라 기능성 식품 소재로서 관심이 높아지고 있다. 현재 GABA는 현미, 녹차, 맥아, 배추 등에 자연적으로 약간 함유되어 있으나, 그 함량이 낮아 자연 식품으로 섭취하는 양으로는 생리활성을 기대하기 어렵다. 이러한 식물들의 GABA 함유량을 높이기 위해서 차잎과 보리맥아 제조시 발아된 보리의 혐기적 처리와 현미 발아시 글루탐산(glutamic acid) 첨가를 통하여 식물체 내 GABA 함량을 증가시켰다(Chang et al., 1992; Jeon et al., 2004; Park et al., 2001; Yokoyama et al., 2002). 그러나 식물을 원재료로 한 GABA의 생산에는 한계가 있으므로 GABA 대량생산을 위해 미생물을 이용한 많은 연구가 수행되고 있다. 이중 젖산균은 인간이 이용할 수 있는 가장 유익한 미생물의 한 종류로서 예로부터 발효 유제품을 중심으로 장류, 김치, 젓갈, 소시지, 의약품 등에 걸쳐 인류생활에 폭넓게 활용되어 내려오고 있다. 하지만, GABA를 생산하는 균주의 분리 및 개량에 대한 연구는 다양한 측면에서 이루어진데 반해 GABA의 함량을 높인 식품이나 기능성 음료에 관한 연구는 아직 미비한 실정이다.
As the function of GABA is known, interest as functional food materials as well as pharmaceuticals is increasing. Currently, GABA is slightly contained in brown rice, green tea, malt, and cabbage, but its content is low and it is difficult to expect physiological activity by the amount of natural food. In order to increase the GABA content of these plants, GABA content in the plant was increased by anaerobic treatment of barley germinated in the preparation of tea leaves and barley malt, and glutamic acid addition during brown germination (Chang et al., 1992; Park et al., 2001; Yokoyama et al., 2002). However, since there is a limit to the production of GABA using plant-based materials, many studies using microorganisms for mass production of GABA have been conducted. Among them, lactic acid bacteria are one of the most beneficial microorganisms that can be used by human beings, and they have been used widely in fermented dairy products, such as soy sauce, kimchi, salted fish, sausages and medicines. However, studies on the isolation and improvement of strains producing GABA have been made in various aspects, but studies on foods or functional beverages having increased contents of GABA have not been studied yet.

한편, 한국등록특허 제0404921호에서는 건망증 개선 효능이 있는 총명차의 제조방법을 개시하고 있으나, 이는 원지, 감초 등의 한방 생약재가 혼합된 총명차로서 젖산균을 이용한 발효나 GABA에 대한 언급이 없다. 따라서, 본 발명자들은 총명탕의 주요 약재로 사용되는 석창포, 원지 및 복령 추출물의 젖산 발효를 통해 GABA 함량을 증진시킨 발효 생약 추출물을 제조하여 본 발명을 완성하였다.On the other hand, Korean Patent No. 0404921 discloses a preparation method of tea ginseng which has ameliorating effect for forgetfulness, but it is not mentioned about fermentation using lactic acid bacteria or GABA as a total ginseng mixed with oriental herb medicine such as Japanese papaya and licorice. Accordingly, the inventors of the present invention have completed the present invention by preparing fermented herbal medicine extracts in which the content of GABA was enhanced through lactic acid fermentation of extracts of Seokchangpo, native and ginseng, which are used as main medicines of Sogwangju.

본 발명의 목적은 젖산균인 락토바실러스 헬베티커스(Lactobacillus helveticus) 스타터를 이용하여 감마-아미노뷰티르산(gamma-aminobutyric acid; GABA)이 증진된 발효 생약 추출물 제조방법을 제공하는 데에 있다.It is an object of the present invention to provide a method for producing a fermented herbal medicine extract in which gamma-aminobutyric acid (GABA) is promoted using lactobacillus Lactobacillus helveticus starter.

본 발명의 다른 목적은 상기의 방법에 의해 제조된 GABA가 증진된 발효 생약 추출물을 제공하는 데에 있다.Another object of the present invention is to provide a GABA-enhanced fermented herbal medicine extract prepared by the above method.

상기 목적을 달성하기 위하여, 본 발명은 배지에서 락토바실러스 헬베티커스를 배양하여 스타터(starter)를 준비하는 단계; 상기 락토바실러스 헬베티커스 스타터를 0.1 내지 10 중량% 글루코즈(glucose) 및 0.1 내지 5 중량% 효모추출물(yeast extract)이 포함된 생약 추출물에 접종하는 단계; 및 상기 접종된 생약추출물을 발효시키는 단계를 포함하는 감마-아미노뷰티르산(gamma-aminobutyric acid; GABA)이 증진된 발효 생약 추출물 제조방법을 제공한다. 상세하게는, 상기 배지에는 0.1 내지 1 중량% 모노소듐 글루타메이트(mono sodium glutamate; MSG)를 더 첨가하는 것을 특징으로 한다.In order to accomplish the above object, the present invention provides a method for culturing Lactobacillus helveticus, comprising culturing Lactobacillus helveticus in a culture medium to prepare a starter; Inoculating the Lactobacillus helveticus starter with a crude drug extract containing 0.1 to 10% by weight glucose and 0.1 to 5% by weight yeast extract; And a step of fermenting the inoculated herbal medicine extract, wherein the gamma-aminobutyric acid (GABA) is promoted. Specifically, the medium is further supplemented with 0.1 to 1% by weight of monosodium glutamate (MSG).

본 발명에 있어서, "스타터(starter)"란 발효물을 제조하는 경우에 사용하는 미생물 배양액을 말한다. 따라서 스타터 미생물의 종류는 그 제품의 특성을 결정하게 되며 제품의 품질에 중요한 영향을 미친다. 미생물 중에서 스타터로 사용되고 있는 것은 박테리아, 곰팡이, 효모 등을 들 수 있으며, 이것을 단독 혹은 혼합하여 사용할 수 있다.In the present invention, the term "starter" refers to a culture medium of microorganisms used for producing a fermented product. Therefore, the types of starter microorganisms determine the characteristics of the product and have an important influence on the quality of the product. Bacteria, fungi, yeast, etc., which are used as starters in microorganisms, can be used alone or in combination.

상기 배지로는 락토바실러스(Lactobacillus) MRS 배지가 바람직하나, 상기 균주의 배양에 적합한 배지라면 특별히 이에 한정되는 것은 아니다. The medium is preferably a Lactobacillus MRS medium, but is not particularly limited as long as it is a medium suitable for culturing the strain.

상기 MSG의 첨가량이 0.1 중량% 이하인 경우 GABA 생성에 필요한 전구물질이 부족하게 되는 문제가 발생할 수 있고, 1.0 중량%을 초과하는 경우 GABA로 전환되지 않은 MSG가 남아 있게 되는 문제가 발생할 수 있다.
If the amount of MSG added is less than 0.1 wt%, the precursor necessary for GABA production may be insufficient. If the amount of MSG is more than 1.0 wt%, MSG not converted to GABA may remain.

또한 본 발명에 있어서, 상기 생약 추출물은 원지, 백복령 및 석창포를 1:1:1의 중량비로 열수 추출한 것을 특징으로 하고, 상기 락토바실러스 헬베티커스는 락토바실러스 헬베티커스(Lactobacillus helveticus) RMK85(KACC91721P)인 것을 특징으로 한다. In the present invention, the herbal extract of the base paper, and baekbokryeong seokchangpo 1: 1: wherein the hot-water extract at a weight ratio of 1, wherein said Lactobacillus helveticus is Lactobacillus helveticus coarse coarse (Lactobacillus helveticus RMK85 (KACC91721P).

본 발명에 있어서, "총명탕"은 백복신, 원지, 감초 및 석창포의 4가지 천연 생약재로 구성된 한약조성물로서 동의보감에는 '치다망구복능일송천언'(治多忘久服能日誦千言)라 하여 '잘 잊어버리는 것을 치료하고 오랫동안 먹으면 능히 하루에 천가지 말을 외우게 된다.'라고 기록되어 있다(출처:네이버 백과사전). 본 발명에서는 원지 300g, 백복령 300g, 석창포 300g을 물 13,000mL와 함께 약탕기에 넣고 120℃에서 총 3시간을 가열하여 생약추출물 또는 총명탕을 제조하였다.
In the present invention, "Sungmyunggang" is a herb medicine composition composed of four natural herbal medicines, such as white ginseng, lavender, liquorice, and licorice root, which is called " If you forget to forget and eat for a long time, you will be able to memorize a thousand words a day. "(Source: Naver Encyclopedia). In the present invention, 300 g of raw paper, 300 g of Baekbokryeong, and 300 g of Seokchangpo were added to a hot water machine together with 13,000 mL of water and heated at 120 캜 for a total of 3 hours to prepare a herbal extract or a common mint.

또한, 상기 접종하는 단계는 상기 락토바실러스 헬베티커스 스타터를 1 내지 10%(v/v) 접종하는 것을 특징으로 하고, 상기 발효시키는 단계는 25 내지 42℃에서 12 내지 72시간 동안 발효하는 것을 특징으로 한다.
The inoculating step is characterized in that 1 to 10% (v / v) of the Lactobacillus helveticus starter is inoculated, and the step of fermenting comprises fermenting at 25 to 42 ° C for 12 to 72 hours .

상기 락토바실러스 헬베티커스 스타터의 접종량이 1 %(v/v) 이하인 경우 저농도의 균주로 인해 감마-아미노부틸산을 고함량으로 생산할 수 없고, 10 %(v/v)을 초과하는 경우 너무 빨리 발효되는 문제가 발생할 수 있다.
When the inoculation amount of the Lactobacillus helveticus starter is less than 1% (v / v), gamma-aminobutyric acid can not be produced in a high content due to low concentration of the strain, and if it exceeds 10% (v / v) The fermentation may occur.

또한, 본 발명은 상기의 방법에 의해 제조된 GABA가 증진된 발효 생약 추출물을 제공한다.In addition, the present invention provides a fermented herbal medicine extract having enhanced GABA produced by the above method.

본 발명자들은 생약 추출물(석창포, 원지 및 복령 추출물)의 젖산 발효를 통해 감마-아미노뷰티르산(gamma-aminobutyric acid; GABA) 함량을 증진시킨 발효 생약 추출물을 제조하였고, 이를 활용하여 고함량의 GABA가 포함된 기능성 음료 및 식품 개발의 가능성을 높일 수 있다.The inventors of the present invention prepared fermented herbal medicine extracts by enhancing the content of gamma-aminobutyric acid (GABA) through lactic acid fermentation of herbal medicine extracts (Seokchangpo, native and extracts) and found that a high content of GABA It is possible to increase the possibility of developing functional beverages and foods containing them.

도 1은 MSG가 첨가된 경우(0.5%)와 첨가되지 않은 경우, 균주 종류에 따른 GABA 생성을 확인한 TLC 결과이다.
도 2는 MRS 배지와 생약 추출물의 비율에 따른 GABA 생산능을 확인한 TLC 결과이다.
도 3은 효모추출물(yeast extract)의 농도에 따른 GABA 생산능을 확인한 TLC 결과이다.
도 4는 스타터(starter) 접종 조건에 따른 GABA 생산능을 확인한 TLC 결과이다.
도 5은 GABA 함량을 증진시킨 발효 생약 추출물을 제조하기 위한 발효공정도를 나타낸다.
FIG. 1 shows the results of TLC in which MSG was added (0.5%) and GABA production was confirmed by strain type when not added.
FIG. 2 shows TLC results showing the ability of GABA production according to the ratio of MRS medium and herbal medicine extract.
FIG. 3 shows the results of TLC showing the ability of GABA production according to the concentration of yeast extract.
FIG. 4 shows TLC results confirming GABA production ability according to starter inoculation conditions.
FIG. 5 shows a fermentation process diagram for preparing a fermented herbal medicine extract having enhanced GABA content.

이하, 하기 실시예를 통해 본 발명을 보다 상세하게 설명한다. 다만, 이러한 실시예에 의해 본 발명이 한정되는 것은 아니다.
Hereinafter, the present invention will be described in more detail with reference to the following examples. However, the present invention is not limited by these examples.

< < 실시예Example 1 > 균주 종류에 따른  1> Depending on the strain type GABAGABA 생성능Generation 확인 Confirm

1. 균주 배양 방법1. Culture method of strain

원유에서 분리한 5가지 균주인 Enterococcus faecalis K48, Lactobacillus helveticus RMK85, Enterococcus faecium K36, Lactobacillus acidophilus RMK 567, Streptococcus macedonicus K49는 Lactobacilli MRS agar 배지(Difco co., Ltd.)에서 단일 콜로니(colony)가 나타나게 배양한 후, MRS 배지(broth)에 모노소듐 글루타메이트(mono sodium glutamate; MSG)를 0.5% 첨가한 구와 첨가하지 않은 구로 나누어 접종한 뒤 30℃에서 24시간 동안 배양하였다.
Five strains isolated from crude oil, Enterococcus faecalis K48, Lactobacillus helveticus RMK85, Enterococcus faecium K36, Lactobacillus acidophilus RMK 567, Streptococcus macedonicus K49 The cells were cultured so that a single colony appeared on Lactobacilli MRS agar medium (Difco co., Ltd.), then cultured in MRS medium broth supplemented with 0.5% monosodium glutamate (MSG) And cultured at 30 ° C for 24 hours.

본 발명의 균주 분리에 사용된 MRS 배지의 조성The composition of the MRS medium used for strain isolation of the present invention 성 분  ingredient 성분비(그람/리터) Component Ratio (grams / liter) 프로테오스 펩톤 #3Proteose Peptone # 3 10.010.0 쇠고기 추출물Beef extract 10.0 10.0 효모 추출물Yeast extract 5.05.0 덱스트로스Dextrose 20.0 20.0 트윈 80Twin 80 1.01.0 암모늄 시트레이트Ammonium citrate 2.02.0 소디움 아세테이트Sodium acetate 5.05.0 마그네슘 설페이트Magnesium sulfate 0.10.1 망간 설페이트Manganese sulfate 0.05 0.05 디포타시움 포스페이트Dipotassium phosphate 2.02.0

2. TLC 측정방법2. TLC measurement method

샘플에 함유된 MSG 및 생성된 GABA 함량은 TLC(Silica gel 60 F254, Merck)로 확인하였다. 배양액 1mL을 speed vaccum을 이용하여 4배 농축하여 TLC plate에 2uL 점적하였다. 분석 시 전개용매로는 아세트산(acetic acid): n-부틸 알콜(n-butyl alcohol): 증류수(distilled water) (2:6:2, v/v/v)의 비율로 조제하여 4시간 이상 포화시킨 용매를 사용하였고, 발색 시약으로 0.2% 닌하이드린 용액(ninhydrin solution)을 분무하여 95℃에서 5분간 발색시켜 스팟(spot)을 확인하였다. 그 결과 락토바실러스 헬베티커스(Lactobacillus helveticus) RMK85가 GABA 생산능이 가장 우수하였으며, MSG 첨가에 의해 GABA 생산량이 높아지는 것을 확인하였다(도 1).
The MSG contained in the sample and the produced GABA content were confirmed by TLC (Silica gel 60 F254, Merck). 1 mL of the culture was concentrated 4 times using a speed vaccum and 2 μL was added to the TLC plate. In the analysis, the developing solvent was acetic acid: n-butyl alcohol: distilled water (2: 6: 2, v / v / v) And a 0.2% ninhydrin solution was sprayed with the coloring reagent. The spot was identified by color development at 95 ° C for 5 minutes. As a result, Lactobacillus helveticus RMK85 showed the highest ability to produce GABA, and that GABA production was increased by addition of MSG (FIG. 1).

< < 실시예Example 2 >  2> MRSMRS 배지 농도에 따른  Depending on the concentration of the medium GABAGABA 생성능Generation 확인 Confirm

MRS 배지 농도에 따른 GABA 생성능을 확인하기 위해서, 원지 300g, 백복령 300g, 석창포 300g을 물 13,000mL와 함께 약탕기에 넣고 120℃에서 총 3시간을 가열하여 미리 제조한 생약추출물에 MRS 배지를 0~100%(v/v)의 농도로 첨가하여 실험하였다. 균주로는 GABA 생성능이 우수한 락토바실러스 헬베티커스(Lactobacillus helveticus) RMK85 균주를 사용하였는데, 이는 MRS 배지에 30℃에서 24시간 동안 배양한 스타터(starter)를 5%(v/v) 첨가하여 24시간 동안 발효하였다. To confirm the GABA production ability according to the MRS medium concentration, 300 g of raw cotton, 300 g of Baekbok-ryeong and 300 g of Seokchangpo were poured into a hot water pot with 13,000 mL of water and heated for 3 hours at 120 ° C. for 3 hours to prepare MRS medium % (v / v). As a strain, Lactobacillus helveticus RMK85 strain, which has excellent GABA production ability, was used. This strain was added to 5% (v / v) starter cultured at 30 ° C for 24 hours in MRS medium, Lt; / RTI &gt;

각각 pH와 총산도(Total acidity)를 측정하였는데, pH는 각 샘플 10mL을 원심 분리한 상층액을 pH meter (Digital pH meter 420A+, Thermo Orion. Beverly, MA., USA)를 이용하여 측정하였고, 적정 산도는 상층액 10mL를 취하여 pH가 8.3에 도달할 때까지 0.1N-NaOH로 적정에 사용된 소비량을 젖산(lactic acid) 함량(%)으로 환산하여 계산하였다.
The pH and total acidity of each sample were measured by centrifuging each sample in 10 mL of the supernatant using a pH meter (Digital pH meter 420A +, Thermo Orion Beverly, MA, USA) The acidity was calculated by taking 10 mL of the supernatant and converting the amount used for titration with 0.1 N-NaOH to the lactic acid content (%) until the pH reached 8.3.

MRS 배지 농도MRS medium concentration pHpH 총산도(Total acidity) (%)Total acidity (%) 0%0% 4.024.02 0.20.2 20%20% 3.853.85 0.580.58 40%40% 3.853.85 0.90.9 60%60% 3.953.95 1.351.35 80%80% 4.024.02 1.681.68 100%100% 4.044.04 1.931.93

그 결과, MRS 배지의 농도가 높아질수록 비교적 좋은 GABA 생산을 하는 것을 확인하였으나(도 2), MRS 배지는 식용으로 적합하지 않은 소재로 판단하여 MRS 배지의 영양성분 중 탄소원과 질소원의 영향을 검토하여 영양원만을 생약 추출물에 첨가하기로 하였다. pH가 감소하고 총산도가 증가하는 것은 락토바실러스 헬베티커스(Lactobacillus helveticus) RMK85 균주가 생장하고 있다는 것을 의미하여 균주의 생장이 활발할 때 GABA 생산도 증가한다고 판단된다(표 2). 즉, 균주의 생장이 활발할 경우 균주가 가지고 있는 글루탐산탈탄산효소(Glutamate decarboxylase)의 활성이 활발해져 기질인 모노소디움글루타메이트(Monosodium Glutamate, MSG)를 분해하여 GABA 생성이 높아지게 된다.
As a result, it was confirmed that the higher the concentration of MRS medium, the better the production of GABA (Fig. 2). However, the MRS medium was judged as not suitable for food, and the influence of carbon source and nitrogen source Only the nutrient source was added to the herbal medicine extract. The decrease in pH and the increase in total acidity are due to Lactobacillus &lt; RTI ID = 0.0 &gt; The means and the helveticus) strains RMK85 growth is determined to increase GABA production when the growth of the strain hwalbalhal (Table 2). That is, when the strain is active, the activity of the glutamate decarboxylase (Glutamate decarboxylase) of the strain becomes active, thereby decomposing the substrate, monosodium glutamate (MSG), resulting in increased GABA production.

< < 실시예Example 3 >  3> YeastYeast extractextract 농도에 따른  Depending on concentration GABAGABA 생성능Generation 확인 Confirm

glucose 2%에 Yeast extract를 1~2.5%까지 농도를 달리하여 젖산발효를 하여 TLC로 GABA 생산능을 측정하였을 때, glucose 2%에 Yeast extract 2%와 2.5%를 첨가한 조건에서 GABA 생산능이 가장 뛰어난 것을 확인하였다(도 3). 한편 pH 및 총산도의 측정 결과, 균주가 생장에도 문제가 없음을 확인하였다(표 3). When 2% of yeast extract was added to 2% of glucose and lactic acid fermentation was performed at 1 ~ 2.5% concentration, GABA production ability was measured by TLC. When 2% of glucose and 2% of yeast extract were added, (Fig. 3). As a result of measurement of pH and total acidity, it was confirmed that there was no problem in growth of the strain (Table 3).

따라서 기본 배지 조성은 생약 추출물을 기본배지로 하여 glucose 2% 와 Yeast extract 2.5%를 사용하였다.
Therefore, 2% of glucose and 2.5% of yeast extract were used as the basic medium for herb extract.

Yeast extract 농도Yeast extract concentration pHpH 총산도(Total acidity) (%)Total acidity (%) 1%One% 3.373.37 1.351.35 1.5%1.5% 3.333.33 1.781.78 2%2% 3.423.42 1.891.89 2.5%2.5% 3.463.46 1.991.99

< < 실시예Example 4 > 스타터( 4> starter starterstarter ) 접종 조건에 따른 ) Depending on the vaccination condition GABAGABA 생산능Production capacity 확인 Confirm

생약 추출물에 glucose 2%와 yeast extract 2.5%를 첨가한 조건에 스타터(starter) 접종 방식을 달리하여 GABA 생산능을 확인하였다. MRS 배지에 락토바실러스 헬베티커스(Lactobacillus helveticus) RMK85 균주를 배양한 스타터(starter)를 5% 접종, MRS 배지에 0.5% MSG를 첨가하여 락토바실러스 헬베티커스(Lactobacillus helveticus) RMK85 균주를 배양한 스타터(starter)를 5% 접종 및 스타터(starter)의 락토바실러스 헬베티커스(Lactobacillus helveticus) RMK85 균체를 모아서 농축하여 접종 조건에서 실험을 수행하였다(표 4). 그 결과, MSG를 0.5% 첨가한 스타터(starter)를 이용한 생약 추출물이 GABA 함량이 가장 많은 것을 확인하였다(도 4).
GABA production ability was determined by adding starter inoculation method to 2% of glucose and 2.5% of yeast extract. MRS medium supplemented with Lactobacillus &lt; RTI ID = 0.0 &gt; helveticus RMK85 strain was inoculated with 5% starter and 0.5% MSG was added to MRS medium to obtain Lactobacillus helveticus ) Starter cultured in RMK85 strain was inoculated into a 5% inoculum and a starter Lactobacillus ( Lactobacillus) helveticus RMK85 cells were collected and enriched and tested under inoculation conditions (Table 4). As a result, it was confirmed that the herbal medicine extract using starter with 0.5% MSG had the highest GABA content (FIG. 4).

SampleSample pHpH 총산도(%)
(Total acidity)
Total acidity (%)
(Total acidity)
흡광도(Absorbance) (660 nm)Absorbance (660 nm)
생약추출물+
Glucose 2%+
Y.E. 2.5%
Herbal extract +
Glucose 2% +
YE 2.5%
Starter 5%Starter 5% 3.503.50 1.501.50 2.7172.717
MSG 0.5%
Starter 5%
MSG 0.5%
Starter 5%
3.583.58 1.401.40 2.7132.713
균체Mycelium 3.473.47 1.401.40 2.8842.884

한편, 상기 각 조건별로 발효된 생약추출물 발효물에 함유된 GABA 함량을 HPLC로 분석한 결과, 발효하지 않은 생약추출물에 비해 발효 후 약 3배 이상 GABA가 증가 되는 것을 확인하였다(표 5).
The GABA content in the fermented herbal extract fermented by each of the above conditions was analyzed by HPLC. As a result, it was confirmed that GABA was increased about 3 times or more after fermentation compared to the fermented herbal medicine extract (Table 5).

조건Condition GABA 함량(ug/mL)GABA content (ug / mL) 생약추출물Herbal extract 31.4031.40 생약추출물+glucose 2%
+Y.E. 2%+Starter 5%
Herbal extract + glucose 2%
+ YE 2% + Starter 5%
45.4445.44
생약추출물+glucose 2%
+Y.E. 2.5%+
Starter 5% (MSG 0.5%)
Herbal extract + glucose 2%
+ YE 2.5% +
Starter 5% (MSG 0.5%)
105.86105.86

농업생명공학연구원Agricultural Biotechnology Research Institute KACC91721KACC91721 2012052320120523

Claims (7)

배지에서 락토바실러스 헬베티커스(Lactobacillus helveticus) RMK85(KACC91721P)을 배양하여 스타터(starter)를 준비하는 단계;
상기 락토바실러스 헬베티커스 스타터를 0.1 내지 10 중량% 글루코즈(glucose) 및 0.1 내지 5 중량% 효모추출물(yeast extract)이 포함된, 원지, 백복령 및 석창포 추출물로 이루어진 생약 추출물에 접종하는 단계; 및
상기 접종된 생약 추출물을 발효시키는 단계를 포함하는 감마-아미노뷰티르산(gamma-aminobutyric acid; GABA)이 증진된 발효 생약 추출물 제조방법.
Culturing Lactobacillus helveticus RMK85 (KACC91721P) in a medium to prepare a starter;
A step of inoculating the herbal medicine extract comprising the extract of Lactobacillus helveticus starter with 0.1 to 10% by weight glucose and 0.1 to 5% by weight of yeast extract; And
A method for producing a fermented herbal medicine extract, wherein gamma-aminobutyric acid (GABA) is enhanced, comprising fermenting the herbal herb extract.
제1항에 있어서, 상기 배지에는 0.1 내지 1 중량% 모노소듐 글루타메이트(mono sodium glutamate; MSG)를 더 첨가하는 것을 특징으로 하는 GABA가 증진된 발효 생약 추출물 제조방법.[2] The method of claim 1, wherein the culture medium further comprises 0.1 to 1% by weight of mono sodium glutamate (MSG). 제1항 또는 제2항에 있어서, 상기 생약 추출물은 원지, 백복령 및 석창포를 1:1:1의 중량비로 열수추출한 것을 특징으로 하는 GABA가 증진된 발효 생약 추출물 제조방법.The method according to claim 1 or 2, wherein the herbal medicine extract is hot water-extracted at a weight ratio of 1: 1: 1 of raw paper, Baekbokryeong and Seokchangpo. 삭제delete 제1항 또는 제2항에 있어서, 상기 접종하는 단계는 상기 락토바실러스 헬베티커스 스타터를 1 내지 10%(v/v) 접종하는 것을 특징으로 하는 GABA가 증진된 발효 생약 추출물 제조방법.The method according to claim 1 or 2, wherein the inoculating step comprises inoculating 1 to 10% (v / v) of the Lactobacillus helveticus starter. 제1항 또는 제2항에 있어서, 상기 발효시키는 단계는 25 내지 42℃에서 12 내지 72시간 동안 발효하는 것을 특징으로 하는 GABA가 증진된 발효 생약 추출물 제조방법.The process according to any one of claims 1 to 5, To 72 hours after the fermentation. 삭제delete
KR1020120086900A 2012-08-08 2012-08-08 Method for producing fermented herb extract with high GABA content using Lactobacillus helveticus RMK85 KR101407231B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020120086900A KR101407231B1 (en) 2012-08-08 2012-08-08 Method for producing fermented herb extract with high GABA content using Lactobacillus helveticus RMK85

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020120086900A KR101407231B1 (en) 2012-08-08 2012-08-08 Method for producing fermented herb extract with high GABA content using Lactobacillus helveticus RMK85

Publications (2)

Publication Number Publication Date
KR20140020470A KR20140020470A (en) 2014-02-19
KR101407231B1 true KR101407231B1 (en) 2014-06-13

Family

ID=50267440

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020120086900A KR101407231B1 (en) 2012-08-08 2012-08-08 Method for producing fermented herb extract with high GABA content using Lactobacillus helveticus RMK85

Country Status (1)

Country Link
KR (1) KR101407231B1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102254560B1 (en) 2020-12-08 2021-05-21 (주)안온바이오 Extract of Liriope platyphylla with increased gaba content and anti-inflammatory composition comprising the same

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102043266B1 (en) * 2018-03-07 2019-12-02 사단법인 제주석창포쉼사업단 A Method for Preparing Fermented Acorus gramineus with a Reduced Content of Beta-Asarone
CN113699067B (en) * 2021-08-24 2023-05-26 杭州娃哈哈科技有限公司 Lactobacillus helveticus, high-yield GABA (gamma-amino acid) direct vat set and application thereof

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20070099144A (en) * 2006-04-03 2007-10-09 황귀서 Composition comprising sungnoiwon for improving brain function and memory dysfunction
KR20110010433A (en) * 2009-07-24 2011-02-01 강원대학교산학협력단 The preparing method for soybean milk with natural gaba using serial fermentation of plant originated lactic acid bacteria with gaba-producing ability and protease-producing ability

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20070099144A (en) * 2006-04-03 2007-10-09 황귀서 Composition comprising sungnoiwon for improving brain function and memory dysfunction
KR20110010433A (en) * 2009-07-24 2011-02-01 강원대학교산학협력단 The preparing method for soybean milk with natural gaba using serial fermentation of plant originated lactic acid bacteria with gaba-producing ability and protease-producing ability

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102254560B1 (en) 2020-12-08 2021-05-21 (주)안온바이오 Extract of Liriope platyphylla with increased gaba content and anti-inflammatory composition comprising the same

Also Published As

Publication number Publication date
KR20140020470A (en) 2014-02-19

Similar Documents

Publication Publication Date Title
JP4815493B2 (en) Medium composition containing fermented gochujang, brewed soy sauce stock or acid-decomposed soy sauce stock, and method for producing γ-aminobutyric acid
CN108260808B (en) Noni enzyme and preparation method thereof
KR101402031B1 (en) Method for producing fermented herb extract with high GABA content using Lactobacillus plantarum K154
CN107937311B (en) Streptococcus thermophilus for high yield of gamma-aminobutyric acid, preservation and culture method and method for preparing fermented milk by using streptococcus thermophilus
KR101407231B1 (en) Method for producing fermented herb extract with high GABA content using Lactobacillus helveticus RMK85
KR101799400B1 (en) Medium composition comprising amino acids for sparassis latifolia mycelium and the production method of the sparassis latifolia mycelium with improved gamma-amino butyrate using the same
KR101091833B1 (en) Methods for preparing high quantity of S-allyl-L-cysteine to fermented products of garlic using lactic acid bacteria
CN109355212B (en) One Aspergillus oryzae ZA132 and its application
KR101530661B1 (en) Method for Preparing Makgeolli Using Monascus sp. and Makgeolli Prepared Thereby
KR101540746B1 (en) Producing method of conjugated linoleic acid
KR101501827B1 (en) Method for manufacturing base of watery radish kimchi using GABA producing Lactobacillus and Opuntia humifusa
KR102007569B1 (en) Fermentation product of seomae mugwort with high palatability and functionality, and method for preparing the same
KR20220094359A (en) Method for manufacturing Morinda citrifolia fortified with higher GABA content using Lactic acid bacteria having GABA-producing activity
KR101842196B1 (en) Functional makgeolli and method for preparation thereof
Lee et al. Chemistry of The Korean Traditional Alcoholic Beverage Makgeolli
KR101976503B1 (en) Medium composition for enhancing alcohol fermentation comprising leaf of yam and alcoholic beverage using the same
KR100963133B1 (en) Function-related fermentation food using the composition which mixed chlorella in Rubus coreanus and method to produce thereof
JP7329221B2 (en) Saccharopolyspora composition and its use in food
KR20150082821A (en) Method for manufacturing lactic acid fermented pudding using sweet pumpkin powder containing lactic acid fermented tumeric
KR101670321B1 (en) Manufacturing method of garlic extract of high quantity Cycloalliin
KR101884999B1 (en) Manufacturing method of Dendropanax morbifera fermentation product having antioxidant function using Lactobacillus sp.
KR101981952B1 (en) Method for producing fermented Fructus Mume soybean paste and fermented Prunus mume soybean paste produced by the same method
KR20140084502A (en) For improving liver function with aloe and Curcuma longa and A method of manufacturing the same and Using the formulations for improving liver function
KR20180044706A (en) Method for preparing corn silk fermentation product enhanced gamma-aminobutyric acid contents
KR20120122263A (en) Manufacturing Method of Fermented Materials for liver function improvement using Acanthopanax sp. extracts and Functional food of Thereof Manufacturing

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20170607

Year of fee payment: 4

FPAY Annual fee payment

Payment date: 20180711

Year of fee payment: 5

FPAY Annual fee payment

Payment date: 20190710

Year of fee payment: 6